by Kenny Smith, RUTHERGLEN MSP James Kelly has welcomed the decision by the Scottish Medicines Consortium (SMC) to approve the use of the prostate cancer drug abiraterone in Scotland.
Abiraterone is a breakthrough prostate cancer drug which can both extend the lives of men with incurable prostate cancer and improve their quality of life. The drug had previously...
Related Stories
Blogs
Audio/Video
Press Releases